{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:11:54Z","timestamp":1789859514551,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.euroneuro.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T13:18:50Z","timestamp":1474031930000},"page":"1775-1783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2516-9075","authenticated-orcid":false,"given":"Andreas","family":"Frick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"\u00c5hs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Wahlstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Bani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Merlo Pich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bettica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"L\u00e5ngstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lubberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Fredrikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Furmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2016.09.004_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/depr.3050010203","article-title":"Monoamine metabolism in human prefrontal cortex and basal ganglia. Pet studies using [\u03b2-11C] l\u20135-hydroxytryptophan and [\u03b2-11C] L-dopa in healthy volunteers and patients with unipolar major depression","volume":"1","author":"\u00c5gren","year":"1993","journal-title":"Depression"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0447.1991.tb05574.x","article-title":"Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers","volume":"83","author":"\u00c5gren","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijpsycho.2014.12.002","article-title":"Human serotonin transporter availability predicts fear conditioning","volume":"98","author":"\u00c5hs","year":"2015","journal-title":"Int. J. Psychophysiol. Fear Learn. Fear Mem. Psychopathol."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00418-013-1081-1","article-title":"Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety","volume":"139","author":"Asan","year":"2013","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archgenpsychiatry.2007.11","article-title":"Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy","volume":"65","author":"Barton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1039\/P19890001331","article-title":"Syntheses of \u03b2-11C-labelled L-tryptophan and 5-hydroxy-L-tryptophan using a multi-enzymatic reaction route","volume":"1","author":"Bjurling","year":"1989","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neubiorev.2014.08.003","article-title":"Neuroimaging in social anxiety disorder \u2013 a meta-analytic review resulting in a new neurofunctional model","volume":"47","author":"Br\u00fchl","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroimage.2006.09.011","article-title":"Biological parametric mapping: a statistical toolbox for multimodality brain image analysis","volume":"34","author":"Casanova","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119100500414","article-title":"5-HT and mechanisms of defence","volume":"5","author":"Deakin","year":"1991","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10253890701300904","article-title":"Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor","volume":"10","author":"Esler","year":"2007","journal-title":"Stress"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib12","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","article-title":"Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia","volume":"164","author":"Etkin","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib13","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/npp.2012.72","article-title":"Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder","volume":"37","author":"Faria","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib14","series-title":"SCID-I: Interview Protocol (Swedish)","author":"First","year":"1998"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib15","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nn1780","article-title":"Capacity for 5-HT1A\u2013mediated autoregulation predicts amygdala reactivity","volume":"9","author":"Fisher","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib16","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/npp.2014.339","article-title":"Fluctuations in [11C]SB207145 PET binding associated with change in threat-related amygdala reactivity in humans","volume":"40","author":"Fisher","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S0033291701004056","article-title":"The Liebowitz social anxiety scale: a comparison of the psychometric properties of self-report and clinician-administered formats","volume":"31","author":"Fresco","year":"2001","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamapsychiatry.2015.2751","article-title":"Use of 5-hydroxytryptophan labeled with carbon 11 in social anxiety disorder \u2013 reply","volume":"73","author":"Frick","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib19","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1038\/tp.2015.92","article-title":"Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171","volume":"5","author":"Frick","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib20","article-title":"Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study","author":"Frick","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/jamapsychiatry.2015.0125","article-title":"Serotonin synthesis and reuptake in social anxiety disorder: a positron emission tomography study","volume":"72","author":"Frick","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s001270050163","article-title":"Social phobia in the general population: prevalence and sociodemographic profile","volume":"34","author":"Furmark","year":"1999","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archpsyc.59.5.425","article-title":"Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy","volume":"59","author":"Furmark","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/0269881116648317","article-title":"Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder","author":"Furmark","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2005.03.029","article-title":"Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo","volume":"58","author":"Furmark","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib26","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1523\/JNEUROSCI.2534-08.2008","article-title":"A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety","volume":"28","author":"Furmark","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib27","first-page":"175794","article-title":"Combining escitalopram and cognitive\u2013behavioural therapy for social anxiety disorder: randomised controlled fMRI trial","volume":"115","author":"Gingnell","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib28","doi-asserted-by":"crossref","unstructured":"Gobbi, G., Blier, P., 2005. Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: Comparison with antidepressant drugs. Peptides, In: International Symposium on Peptide Receptors, Montr\u00e9al 2004: from Gene to Therapy 26, 1383\u20131393, doi:\u00a010.1016\/j.peptides.2005.03.032.","DOI":"10.1016\/j.peptides.2005.03.032"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/01.WCB.0000040946.89393.9d","article-title":"Kinetic compartment modeling of [11C]-5-hydroxy-L-tryptophan for positron emission tomography assessment of serotonin synthesis in human brain","volume":"22","author":"Hagberg","year":"2002","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib30","doi-asserted-by":"crossref","first-page":"e6797","DOI":"10.1371\/journal.pone.0006797","article-title":"Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain","volume":"4","author":"Honig","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib31","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0028-3908(84)90099-6","article-title":"5-HT and anxiety","volume":"23","author":"Iversen","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamapsychiatry.2015.2466","article-title":"Use of 5-hydroxytryptophan labeled with carbon 11 in social anxiety disorder","volume":"73","author":"Jacobsen","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1471-4159.1974.tb06941.x","article-title":"Decarboxylation of exogenous l-5-hydroxytryptophan after destruction of the cerebral raphe system","volume":"23","author":"Korf","year":"1974","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biopsych.2006.05.022","article-title":"Reduced serotonin-1A receptor binding in social anxiety disorder","volume":"61","author":"Lanzenberger","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib35","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","article-title":"An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets","volume":"19","author":"Maldjian","year":"2003","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pscychresns.2013.08.012","article-title":"Altered neural correlates of affective processing after internet-delivered cognitive behavior therapy for social anxiety disorder","volume":"214","author":"M\u00e5nsson","year":"2013","journal-title":"Psychiatry Res.: Neuroimaging"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib37","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.2174\/138161212803530844","article-title":"Neuroimaging of serotonin system in anxiety disorders","volume":"18","author":"Maron","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib38","first-page":"1","article-title":"Emerging drugs for the treatment of anxiety","author":"Murrough","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib39","doi-asserted-by":"crossref","first-page":"pyv018","DOI":"10.1093\/ijnp\/pyv018","article-title":"Differences in anxiety-like behaviour within a batch of Wistar rats are associated with differences in serotonergic transmission, enhanced by acute SSRI administration and abolished by serotonin depletion","volume":"18","author":"N\u00e4slund","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.euroneuro.2016.09.004_bib40","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0924-977X(99)00030-9","article-title":"Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders","volume":"9","author":"Nutt","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.biopsych.2012.10.003","article-title":"Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia","volume":"73","author":"Phan","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib42","series-title":"Psychiatric Disorders \u2013 Trends and Developments","article-title":"Neurotransmitter and Behaviour: serotonin and Anxiety","author":"Rex","year":"2011"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib43","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1523\/JNEUROSCI.1175-07.2007","article-title":"Human 5-HT transporter availability predicts amygdala reactivity in vivo","volume":"27","author":"Rhodes","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00213-005-0247-5","article-title":"5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats","volume":"185","author":"Salchner","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib45","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1097\/00001756-199912160-00044","article-title":"Serotonin and substance P co-exist in dorsal raphe neurons of the human brain","volume":"10","author":"Sergeyev","year":"1999","journal-title":"Neuroreport"},{"issue":"Suppl 20","key":"10.1016\/j.euroneuro.2016.09.004_bib46","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"Suppl 2059","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/npp.2009.83","article-title":"The neurocircuitry of fear, stress, and anxiety disorders","volume":"35","author":"Shin","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib48","unstructured":"Spielberger, C.D., Gorsuch, R.L., Lushene, R.E., 1970. Manual for the State-Trait Anxiety Inventory"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib49","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroimage.2004.10.017","article-title":"MR-based automatic delineation of volumes of interest in human brain PET images using probability maps","volume":"24","author":"Svarer","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib50","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00259-010-1663-2","article-title":"Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications","volume":"38","author":"Visser","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.euroneuro.2016.09.004_bib51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2967\/jnumed.107.045518","article-title":"Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT","volume":"49","author":"van der Wee","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.euroneuro.2016.09.004_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neubiorev.2014.03.007","article-title":"Serotonin in anxiety and panic: contributions of the elevated T-maze","volume":"3","author":"Zangrossi","year":"2014","journal-title":"Neurosci. Biobehav. Rev. Transl. Approaches Panic Disord."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16301821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16301821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T07:05:24Z","timestamp":1536390324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X16301821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0924977X16301821"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.09.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}